Metraipolis › archive › dc_0184dca475e3

Metabolic Reprogramming in Lung Cancer: Hallmarks, Mechanisms, and Targeted Strategies to Overcome Immune Resistance — Europe PMC PMID:41163383

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41163383
DOI
10.1002/cam4.71317
License (as archived)
solo-consultazione
Archived
2026-11-08T20:52:37.547Z
SHA-256 of the archived text
ce14e19820322979961a15ee5355cb18bbc3566957fe1aa85c6da4b5a419a004
Stable URL of this page
https://metraipolis.com/documento/dc_0184dca475e3

How to cite

Metabolic Reprogramming in Lung Cancer: Hallmarks, Mechanisms, and Targeted Strategies to Overcome Immune Resistance — Europe PMC PMID:41163383 — Europe PMC (en), https://europepmc.org/article/MED/41163383 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0184dca475e3 (Metraipolis archive dc_0184dca475e3, sha256 ce14e19820322979961a15ee5355cb18bbc3566957fe1aa85c6da4b5a419a004)
BibTeX
@misc{dc0184dca475e3,
  title = {Metabolic Reprogramming in Lung Cancer: Hallmarks, Mechanisms, and Targeted Strategies to Overcome Immune Resistance — Europe PMC PMID:41163383},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41163383},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0184dca475e3; sha256 ce14e19820322979961a15ee5355cb18bbc3566957fe1aa85c6da4b5a419a004},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41163383. Agents can read the archived copy with the MCP tool read_document.